Long-term durable response after treatment of metastatic salivary duct carcinoma with pembrolizumab

Document Type

Article

Publication Title

JCO Oncology Practice

First Page

397

Last Page

398

DOI

10.1200/JOP.19.00626

Publication Date

7-1-2020

This document is currently not available here.

Share

COinS